Stock A080720 UNION KOREA PHARM CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Union Korea Pharm Co., Ltd.

Equities

A080720

KR7080720006

Pharmaceuticals

End-of-day quote Korea S.E.
Other stock markets
 18:00:00 2024-05-22 EDT 		5-day change 1st Jan Change
6,180 KRW -0.16% Intraday chart for Union Korea Pharm Co., Ltd. -1.28% +24.85%
04-25 Union Korea Pharm Co., Ltd. announced that it expects to receive KRW 5 billion in funding from Mark420 Co., Ltd, NBH Capital Inc. and other investors CI
2023 Union Korea Pharm Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 76,121 82,062 145,429 78,193 51,626 35,741
Enterprise Value (EV) 1 77,195 103,090 157,584 92,940 81,227 67,910
P/E ratio 11.4 x 200 x -12.9 x -7.1 x -56.6 x -1.97 x
Yield - - - - - -
Capitalization / Revenue 1.39 x 1.6 x 2.89 x 1.62 x 0.84 x 0.57 x
EV / Revenue 1.41 x 2.01 x 3.13 x 1.92 x 1.33 x 1.08 x
EV / EBITDA 7.99 x 31.6 x -22.2 x -14.5 x 15.4 x -6.29 x
EV / FCF -9.78 x -7.34 x -41.2 x 11.8 x -6.08 x -9.02 x
FCF Yield -10.2% -13.6% -2.43% 8.47% -16.5% -11.1%
Price to Book 1.35 x 1.41 x 2.13 x 1.47 x 1.06 x 1.18 x
Nbr of stocks (in thousands) 5,745 5,904 7,904 7,704 7,220 7,220
Reference price 2 13,250 13,900 18,400 10,150 7,150 4,950
Announcement Date 19-03-19 20-03-16 21-03-23 22-03-23 23-03-23 24-03-21
1KRW in Million2KRW
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 54,662 51,264 50,379 48,304 61,293 63,169
EBITDA 1 9,659 3,266 -7,084 -6,389 5,266 -10,792
EBIT 1 7,768 791.3 -10,832 -10,615 1,271 -14,682
Operating Margin 14.21% 1.54% -21.5% -21.97% 2.07% -23.24%
Earnings before Tax (EBT) 1 6,854 586.3 -12,084 -14,477 943.5 -14,404
Net income 1 5,828 411.2 -9,322 -11,109 -932 -18,156
Net margin 10.66% 0.8% -18.5% -23% -1.52% -28.74%
EPS 2 1,158 69.53 -1,431 -1,430 -126.3 -2,514
Free Cash Flow 1 -7,896 -14,054 -3,824 7,871 -13,368 -7,528
FCF margin -14.44% -27.41% -7.59% 16.3% -21.81% -11.92%
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 19-03-19 20-03-16 21-03-23 22-03-23 23-03-23 24-03-21
1KRW in Million2KRW
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 1,074 21,028 12,155 14,747 29,601 32,169
Net Cash position 1 - - - - - -
Leverage (Debt/EBITDA) 0.1111 x 6.439 x -1.716 x -2.308 x 5.622 x -2.981 x
Free Cash Flow 1 -7,896 -14,054 -3,824 7,871 -13,368 -7,528
ROE (net income / shareholders' equity) 14.1% 0.71% -14.7% -18.2% -1.82% -46%
ROA (Net income/ Total Assets) 6.66% 0.54% -6.99% -6.14% 0.69% -8.87%
Assets 1 87,464 75,720 133,307 181,048 -135,804 204,737
Book Value Per Share 2 9,792 9,833 8,650 6,925 6,733 4,196
Cash Flow per Share 2 2,131 880.0 197.0 2,733 833.0 910.0
Capex 1 5,479 16,017 7,844 7,168 3,366 2,263
Capex / Sales 10.02% 31.24% 15.57% 14.84% 5.49% 3.58%
Announcement Date 19-03-19 20-03-16 21-03-23 22-03-23 23-03-23 24-03-21
1KRW in Million2KRW
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Specialty & Advanced Pharmaceuticals

1st Jan change Capi.
UNION KOREA PHARM CO., LTD. Stock Union Korea Pharm Co., Ltd.
+24.85% 32.75M
KYOWA KIRIN CO. LTD. Stock Kyowa Kirin Co. Ltd.
+7.68% 8.74B
SK BIOPHARMACEUTICALS CO., LTD. Stock SK Biopharmaceuticals Co., Ltd.
-15.14% 4.94B
SHENYANG XINGQI PHARMACEUTICAL CO.,LTD. Stock Shenyang Xingqi Pharmaceutical Co.,Ltd.
+50.73% 4.7B
YUHAN CORPORATION Stock Yuhan Corporation
+4.36% 3.98B
BETTA PHARMACEUTICALS CO., LTD. Stock Betta Pharmaceuticals Co., Ltd.
-26.13% 2.28B
INDIVIOR PLC Stock Indivior PLC
+12.07% 2.28B
SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD. Stock Shanghai Shyndec Pharmaceutical Co., Ltd.
+16.45% 2.14B
CHANGCHUN BCHT BIOTECHNOLOGY CO. Stock Changchun BCHT Biotechnology Co.
-33.59% 2.12B
VELOXIS PHARMACEUTICALS A/S Stock Veloxis Pharmaceuticals A/S
-0.50% 1.64B
Specialty & Advanced Pharmaceuticals
  1. Stock Market
  2. Equities
  3. A080720 Stock
  4. Financials Union Korea Pharm Co., Ltd.